Saltar al contenido
Dispositivos y mediciónEstudio/revisión de validación3 min read

Apple Watch and a finger oximeter both overestimate blood oxygen when it drops low

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Performance of Wearable Pulse Oximetry During Controlled Hypoxia Induction: Instrument Validation Study. · JMIR formative research · 2026 · Artículo original ↗

Idea principal

During controlled low-oxygen conditions, both the Apple Watch Series 7 and a Masimo MightySat Rx finger oximeter overestimated oxygen saturation, and below 88% the Apple Watch error (Arms 5.82%, 95% CI 5.32%-6.31%) was larger than the Masimo's (3.52%, 3.18%-3.86%). The sample was small and not diverse in skin tone or age, so the error sizes may differ in other people.

Study design

Estudio/revisión de validación

Reading basis

Published abstract

Reading focus

Reference & error

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

People with lung disease or sleep apnea can drop to dangerously low blood oxygen, so a wearable that misses those drops could give false reassurance. The authors tested how accurate the Apple Watch Series 7 and a clinical-grade finger oximeter are against blood samples during induced low oxygen, and whether faster oxygen drops make errors larger.

Población y método

Instrument validation study. During controlled hypoxia induction, the authors calculated the oxygen desaturation rate (ODR) for each measurement and compared the displayed oxygen saturation (SpO2) from the Masimo MightySat Rx and the Apple Watch Series 7 with arterial blood oxygen saturation (SaO2) from a blood gas analyzer, the reference. Accuracy was summarized as the root mean square difference (Arms). The abstract does not give the number of participants or the exact protocol.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Both devices tended to overestimate oxygen saturation. Readings fell within 2% of the acceptable error range (as specified by Masimo) 49.03% of the time for the finger oximeter versus 32.14% for the Apple Watch.
  2. 2
    When oxygen saturation was below 88%, accuracy worsened: Arms was 3.52% (95% CI 3.18%-3.86%) for the Masimo MightySat Rx and 5.82% (95% CI 5.32%-6.31%) for the Apple Watch Series 7. Both exceeded the US Food and Drug Administration threshold under hypoxemia.
  3. 3
    The Apple Watch's average bias suggests it could miss hypoxemia, particularly when true saturation is just below 88%.
  4. 4
    During fast desaturation (at least 2% SpO2 per minute, a rate linked to sleep apnea), Arms rose by 0.75% for the Masimo and fell by 0.28% for the Apple Watch. The authors found no statistically significant relationship between desaturation rate and measurement error for either device.

Límites e incertidumbre

  1. 1
    The authors state the sample was small, so estimates (and the ODR null result) are imprecise, and the abstract gives no participant count.
  2. 2
    Skin tone and age were of limited diversity, which matters because optical oximeters can behave differently across skin tones and ages.
  3. 3
    Hypoxia was induced under controlled conditions, so accuracy during real sleep, exercise or movement is not shown. This reading is based on the abstract only.

Relevancia práctica

Wrist and finger oxygen readings are best seen as rough indicators, particularly once saturation is low, where both devices read higher than the true value. A normal-looking reading should not override symptoms such as breathlessness. Anyone with lung disease or suspected sleep apnea should rely on their clinician for diagnosis and monitoring choices.

Tus datos

If your watch logs SpO2, compare readings from the same device, wrist position and conditions (for example overnight in the same bed) and look at trends rather than single values. Do not treat a normal-looking value as proof that oxygen is safe if you feel unwell.

Cómo interpretar la evidencia

Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Oxygen saturation is a crucial metric used for monitoring patients with lung disease or respiratory illness who are at risk of hypoxemia (low blood oxygen saturation). Early and accurate identification of abnormal oxygen saturation is important for these patients, who may develop significant desaturation and hypoxemia symptoms during their daily activities.

Objective

This study aimed to evaluate the accuracy of Apple Watch Series 7 and a clinical-grade pulse oximeter, Masimo MightySat Rx, under hypoxemia and to assess whether measurement error is influenced by the oxygen desaturation rate (ODR).

Methods

We calculated the ODR of each measurement and conducted a comparative analysis of the displayed oxygen saturation readings from both the Masimo MightySat Rx finger pulse oximeter and Apple Watch Series 7 with arterial blood oxygen saturation (SaO2) readings obtained from a blood gas analyzer.

Results

Both the Masimo MightySat Rx pulse oximeter and the Apple Watch Series 7 tended to overestimate oxygen saturation. The pulse oximeter readings were more likely to fall within 2% of the acceptable (as specified by Masimo) peripheral oxygen saturation (SpO₂) error range than the Apple Watch (49.03% vs 32.14%). Notably, both devices had limitations under low oxygen saturation levels (<88%), with an accuracy root mean square difference (Arms) of 3.52% (95% CI 3.18%-3.86%) and 5.82% (95% CI 5.32%-6.31%) for the Masimo MightySat Rx and Apple Watch Series 7, respectively. Among the blood oxygen measurements taken during a high ODR (ie, ≥2% SpO2 per minute), which is a rate clinically correlated with sleep apnea, the Arms increased slightly by 0.75% for the Masimo MightySat Rx and decreased by 0.28% for the Apple Watch Series 7.

Conclusions

Both devices consistently overestimated SpO2, with accuracy declining notably during hypoxemia. The Apple Watch Series 7 mean bias suggests a likelihood of missing instances of hypoxemia, particularly at arterial oxygen saturation values below but close to 88%. Both the Apple Watch Series 7 and Masimo MightySat Rx exhibited Arms values exceeding the US Food and Drug Administration threshold under conditions of hypoxemia. While past studies have implicated high ODRs in increasing measurement error, we found no statistically significant relationship between ODR and measurement error for either device. Overall, our findings of SpO2 overestimation and high Arms values underscore the need for caution when interpreting oxygen saturation values from these devices. The small sample size and limited diversity in skin tone and age restrict the generalizability of our findings. Future studies should include larger and more diverse populations to evaluate the performance of wearable-based pulse oximetry.

Fuentes y atribución

Performance of Wearable Pulse Oximetry During Controlled Hypoxia Induction: Instrument Validation Study.

Jiang Y, Spies C, Roghanizad AR, Wang WK, Bhosai SJ, Snyder L, Burke A, MacLeod D, Dunn J.

JMIR formative research · 2026-03-27

DOI: 10.2196/85253 ↗PubMed · 41894520 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Estudio de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explicaciones detalladasLeer estudio →
·Revisión de revisiones

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explicaciones detalladasLeer estudio →
Dispositivos y medición →